<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04241406</url>
  </required_header>
  <id_info>
    <org_study_id>aamg295</org_study_id>
    <nct_id>NCT04241406</nct_id>
  </id_info>
  <brief_title>Transcutaneous Spinal Cord Stimulation in Healthy Subjects to Activate Central Pattern Generator</brief_title>
  <official_title>Transcutaneous Spinal Cord Stimulation in Healthy Subjects to Activate Central Pattern Generator: Double-blind, Randomised, Controlled Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Castilla-La Mancha</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Nacional de Parapléjicos de Toledo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Castilla-La Mancha</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determinate whether the application of transcutaneous spinal
      cord stimulation produce changes in the excitability of alpha moto neurone in healthy
      volunteers. Moreover evidence whether the effect of the electric currents can increase muscle
      strength.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the last years several experimental studies have evidenced that the transcutaneous spinal
      cord stimulation (tSCS) can evoque spinal reflex activity. The activation of propioceptive
      afferent would then activated motoneurons innervated at the same metameric and adjacent
      levels. The possibility of activating neural networks with non-invasive stimulation method
      opens a therapeutic window for the treatment of different neurological disorders. So the
      purpose of this study is quantify the modulation of the excitability of alpha motor neurone
      when the application of the current is in the central nervous system compared with a sham
      group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 30, 2019</start_date>
  <completion_date type="Actual">March 31, 2020</completion_date>
  <primary_completion_date type="Actual">February 3, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Baseline Motor evoked potential (MEP)</measure>
    <time_frame>baseline at 0 min.</time_frame>
    <description>The action potential elicited by transcranial magnetic stimulation of the motor cortex through the scalp. EMG response will be recorded by surface electrodes (Signa lConditioning Electrodes v2.3, Delsys Inc., USA) fixed in quadriceps and tibialis anterior muscles. by the SENIAM protocol (www.seniam.org).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>During treatment Motor evoked potential (MEP)</measure>
    <time_frame>During treatment at 5 min.</time_frame>
    <description>The action potential elicited by transcranial magnetic stimulation of the motor cortex through the scalp. EMG response will be recorded by surface electrodes (Signa lConditioning Electrodes v2.3, Delsys Inc., USA) fixed in quadriceps and tibialis anterior muscles. by the SENIAM protocol (www.seniam.org).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-treatment 1 Motor evoked potential (MEP)</measure>
    <time_frame>At 2 min after treatment.</time_frame>
    <description>The action potential elicited by transcranial magnetic stimulation of the motor cortex through the scalp. EMG response will be recorded by surface electrodes (Signa lConditioning Electrodes v2.3, Delsys Inc., USA) fixed in quadriceps and tibialis anterior muscles. by the SENIAM protocol (www.seniam.org).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-treatment 2 Motor evoked potential (MEP)</measure>
    <time_frame>At 4 min after treatment.</time_frame>
    <description>The action potential elicited by transcranial magnetic stimulation of the motor cortex through the scalp. EMG response will be recorded by surface electrodes (Signa lConditioning Electrodes v2.3, Delsys Inc., USA) fixed in quadriceps and tibialis anterior muscles. by the SENIAM protocol (www.seniam.org).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Baseline Strength</measure>
    <time_frame>Baseline at 0 min.</time_frame>
    <description>Hand dynamometer will be used to measure muscle strength. 3 trial of 3 second of isometric muscle contraction of quadriceps and tibialis anterior will be carried.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-treatment Strength</measure>
    <time_frame>At 8 min after treatment.</time_frame>
    <description>Hand dynamometer will be used to measure muscle strength. 3 trial of 3 second of isometric muscle contraction of quadriceps and tibialis anterior will be carried.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Motor Activity</condition>
  <arm_group>
    <arm_group_label>transcutaneous spinal cord stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcutaneous application of electrical (biphasic current, 1ms, 30Hz) stimulation over the back for a 10 minutes session.The intensity of the current will increase until motor reflex threshold. If it will not possible, intensity will be increase until participants report a &quot;strong but comfortable&quot; sensation.
Transcutaneous electrical stimulation over back through the electrotherapy device Myomed 932. (Enraf-Nonius, Delft, Netherlands).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electrodes are placed over the back for a 10 minutes in the same manner as experimental groups, but will be applied a sham electrical stimulation increasing current intensity during 30 second and decrease intensity subsequently.
Sham transcutaneous electrical stimulation over back through the electrotherapy device Myomed 932. (Enraf-Nonius, Delft, Netherlands).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous spinal cord stimulation</intervention_name>
    <description>Electrodes are placed over the back for a 10 minutes in the same manner as experimental groups, but will be applied a sham electrical stimulation increasing current intensity during 30 second and decrease intensity subsequentl</description>
    <arm_group_label>sham stimulation</arm_group_label>
    <arm_group_label>transcutaneous spinal cord stimulation</arm_group_label>
    <other_name>tSCS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants will be volunteer healthy students of Physiotherapy, University of
             Castilla - La Mancha, older than 18 years.

        Exclusion Criteria:

          -  Neuromuscular disease.

          -  Epilepsy.

          -  Trauma, surgery or pain affecting the upper limb, shoulder girdle or lumbar área.

          -  Osteosynthesis material in the upper limb.

          -  Diabetes.

          -  Cancer.

          -  Cardiovascular disease.

          -  Pacemaker or other implanted electrical device.

          -  Take any drug (NSAIDs, corticosteroids, antidepressants, analgesics, antiepileptics,
             ...) during the study and in the previous 7 days.

          -  Presence of tattoos or other external agent introduced into the treatment or
             assessment area.

          -  Pregnancy.

          -  Sensitivity disturbance in lower limb.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julio Gómez-Soriano, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Castilla-La Mancha University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Julio</name>
      <address>
        <city>Toledo</city>
        <zip>45001</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Álvaro</name>
      <address>
        <city>Toledo</city>
        <zip>45001</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diego Serrano-Muñoz</name>
      <address>
        <city>Toledo</city>
        <zip>45004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>January 22, 2020</study_first_submitted>
  <study_first_submitted_qc>January 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2020</study_first_posted>
  <last_update_submitted>April 30, 2020</last_update_submitted>
  <last_update_submitted_qc>April 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>transcutaneous spinal cor stimulation</keyword>
  <keyword>neuromodulation</keyword>
  <keyword>motor activity</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

